Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones
about
Depurinating estrogen-DNA adducts, generators of cancer initiation: their minimization leads to cancer preventionAlcohol drinking and mammary cancer: Pathogenesis and potential dietary preventive alternativesThe molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessityMechanism-Based Inhibition of Quinone Reductase 2 (NQO2): Selectivity for NQO2 over NQO1 and Structural Basis for Flavoprotein InhibitionIn Silico Screening Reveals Structurally Diverse, Nanomolar Inhibitors of NQO2 That Are Functionally Active in Cells and Can Modulate NF- B SignalingUrinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphomaCytoprotection "gone astray": Nrf2 and its role in cancerMass spectrometry techniques in the survey of steroid metabolites as potential disease biomarkers: a review.N-acetylcysteine blocks formation of cancer-initiating estrogen-DNA adducts in cells.Effects of developmental exposure to mixtures of environmental contaminants on the hepatic metabolism of estradiol-17β in immature female Sprague Dawley rats.Interaction of 14-3-3σ with KCMF1 suppresses the proliferation and colony formation of human colon cancer stem cells.Imbalanced estrogen metabolism in the brain: possible relevance to the etiology of Parkinson's diseaseUnbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer.Resveratrol and N-acetylcysteine block the cancer-initiating step in MCF-10F cellsNAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.Evaluation of serum estrogen-DNA adducts as potential biomarkers for breast cancer risk.Prevention of estrogen-DNA adduct formation in MCF-10F cells by resveratrol.Genome-wide analysis of long noncoding RNA (lncRNA) expression in colorectal cancer tissues from patients with liver metastasis.Novel biomarkers for risk of prostate cancer: results from a case-control study.Short-term Exposure to 50-Hz Electromagnetic Field and Alterations in NQO1 and NQO2 Expression in MCF-7 Cells.Critical depurinating DNA adducts: Estrogen adducts in the etiology and prevention of cancer and dopamine adducts in the etiology and prevention of Parkinson's disease.Indolequinone inhibitors of NRH:quinone oxidoreductase 2. Characterization of the mechanism of inhibition in both cell-free and cellular systems.Interplay of flavin's redox states and protein dynamics: an insight from QM/MM simulations of dihydronicotinamide riboside quinone oxidoreductase 2.Association of superoxide dismutases and NAD(P)H quinone oxidoreductases with prognosis of patients with breast carcinomas.Evidence for NQO1 and NQO2 catalyzed reduction of ortho- and para-quinone methides.Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.The ontogeny and population variability of human hepatic dihydronicotinamide riboside:quinone oxidoreductase (NQO2).
P2860
Q26765412-CAF4D11A-AE4E-43B2-9721-366B45DFB2D6Q26825714-E76FB968-9D89-42A0-A1B9-C3BD2B714E66Q27021258-88E845F1-0480-46CF-BE35-02F6B5B3EEE5Q27667472-3D79FD11-1876-416F-9B61-1121708B0E9BQ27675614-F36F0A67-C54A-406F-9665-797792C1C088Q28393521-3CAA317C-9502-400C-9C9E-08FEA5D52AEFQ28393784-34801899-FEA0-4351-AA76-F7789D8E1D05Q33457880-FD233DC7-CD79-49B6-AD54-B85079FC04B4Q33976415-5C533164-D133-4B31-B60D-F91DC648F9BCQ34390238-0B67B8CA-7C31-4181-8A85-A8FCAA969DB8Q34804121-7842D7E7-BB54-4EDD-9FEE-2992B3A3B79FQ35124298-B2079374-B4A5-4B55-821A-C767A23509EFQ35580183-C2F11093-5E48-4837-9CEC-E6EF3E39804CQ35586128-1864D14C-E934-468C-B2D1-41587DB39D7CQ35586131-E8E373E1-F604-48B1-A67D-F6F96A0EA668Q36044347-866DBF06-F2DF-4BBF-A3E7-7361A1B093A4Q36807739-905D1177-45E1-4128-A94C-3EE749ED2A7FQ36903253-5D61DD91-5F06-4072-BCFC-560FDE05952FQ36987110-763542AD-6A23-4476-A814-E9C2074DCF62Q37523517-BC93C7FC-D413-4075-9DB3-008059C3AA32Q39227100-D67A1BFA-2FFA-43CC-9700-A35934E9E906Q39515397-2278CF67-0BE5-44E1-AC6D-08E0E373F622Q42709596-71D3CB99-0CAB-4539-B449-1DF568F312F8Q44221204-5D97C69B-9449-4C44-B4B6-F738E4927E07Q46402017-C635DB86-F385-4185-9D0E-44BA8C28BB21Q47251583-3205DDC7-7C83-4E17-9DC4-A4AB3983EF7BQ50770722-3632917C-CEE4-4ABC-8A05-EAEDD8115C07
P2860
Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones
@en
Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones.
@nl
type
label
Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones
@en
Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones.
@nl
prefLabel
Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones
@en
Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones.
@nl
P2093
P2860
P1476
Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones
@en
P2093
Eleanor G Rogan
Ercole L Cavalieri
Nilesh W Gaikwad
P2860
P304
P356
10.1016/J.FREERADBIOMED.2008.10.029
P577
2008-11-01T00:00:00Z